株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

癌治療用インターベンションデバイスの世界市場:分析と予測 (2019-2025年)

Global Interventional Oncology Devices Market: Focus on Devices/Therapies Cancer Types, Regional Analysis, Data - Analysis and Forecast, 2019-2025

発行 BIS Research Inc. 商品コード 913747
出版日 ページ情報 英文 196 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
癌治療用インターベンションデバイスの世界市場:分析と予測 (2019-2025年) Global Interventional Oncology Devices Market: Focus on Devices/Therapies Cancer Types, Regional Analysis, Data - Analysis and Forecast, 2019-2025
出版日: 2019年09月30日 ページ情報: 英文 196 Pages
概要

世界の癌治療用インターベンションデバイス市場は、2019年から2025年の予測期間中、9.0%のCAGR (年間複合成長率) で拡大すると予測されています。同市場は2018年に22億米ドルの収益を生成しました。

当レポートでは、世界の癌治療用インターベンションデバイス市場について調査分析し、市場力学、競合情勢、産業分析、セグメント別の市場分析と予測、地域別分析、主要企業について、体系的な情報を提供しています。

913747_Figure 3 Global Interventional Oncology Devices Market, 2018-2025

エグゼクティブサマリー

第1章 製品定義

第2章 調査範囲

第3章 調査手法

第4章 産業分析

第5章 競合情勢

  • 主な戦略・発展
  • ベンダーの市場シェア分析

第6章 市場力学

  • 概要
  • 影響分析
  • 市場促進要因
  • 市場課題
  • 市場機会
  • 市場抑制要因

第7章 世界の癌治療用インターベンションデバイス市場:癌種類別

  • 概要
  • 肝臓癌
  • 肺癌
  • 腎臓癌
  • 前立腺癌
  • その他の癌

第8章 世界の癌治療用インターベンションデバイス市場:製品タイプ別

  • 概要
  • アブレーションデバイス
  • 塞栓デバイス
  • サポートデバイス
  • 次世代デバイス

第9章 世界の癌治療用インターベンションデバイス市場:地域別

  • 世界の概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第10章 企業プロファイル

  • 概要
  • AngioDynamics, Inc.
  • BD
  • Boston Scientific Corporation
  • BTG Plc
  • Eckert & Ziegler BEBIG
  • HealthTronics, Inc.
  • IceCure Medical
  • Medtronic PLC
  • Medwaves, Inc.
  • Merit Medical Systems, Inc.
  • Sanarus Technologies, Inc.
  • Sirtex Medical Ltd. (China Grand Pharmaceutical and Healthcare Holdings Limited; CDH Genetech, Ltd.)
  • Sonacare Medical
  • テルモ
  • Trod Medical
図表

List of Tables

  • Table 4.1: Regulatory Bodies Related to Interventional Oncology Devices (by Country)
  • Table 6.1: Impact Analysis of Market Drivers
  • Table 6.2: Impact Analysis of Market Challenges
  • Table 6.3: Global Age Standardized Cancer Rates (Per 100,000 People) by Country, 2018
  • Table 6.4: Reimbursement Scenario for Hepatic Embolization in U.S., 2018
  • Table 6.5: Reimbursement Scenario for Renal Embolization in U.S., 2018
  • Table 9.1: Canadian Cancer Statistics 2019 Snapshot of Incidence, Mortality and Survival Estimates (by Cancer Type)

List of Figures

  • Figure 1: Global Interventional Oncology Devices Market: Market Segmentation
  • Figure 2: Market Statistics
  • Figure 3: Global Interventional Oncology Devices Market, 2018-2025
  • Figure 4: Market Drivers and Market Restraints
  • Figure 5: Financial Burden of Cancer (2015)
  • Figure 6: Share of Prevalence of Cancer in Global Population
  • Figure 7: Number of People with Cancer (by Age) in Global Population
  • Figure 8: Growth Share Matrix of Interventional Oncology Devices Market, by Products, 2019-2025
  • Figure 9: Global Interventional Oncology Devices Market, by Cancer Type, 2018 and 2025
  • Figure 10: Global Interventional Oncology Devices Market, by Geography, 2018 and 2025
  • Figure 11: Competitive Scenario
  • Figure 2.1: Global Interventional Oncology Devices Market: Market Segmentation
  • Figure 3.1: Interventional oncology devices Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.6: Assumptions and Limitations
  • Figure 3.7: Factors Considered for Data Prediction and Modeling
  • Figure 4.1: Share of Patents (by Ownership), 2015-2018
  • Figure 5.1: Competitive Landscape, January 2015-February 2019
  • Figure 5.2: Share of Key Developments and Strategies, January 2015-February 2019
  • Figure 5.3: Product Launches (by Company), January 2015-February 2019
  • Figure 5.4: Collaborations, Joint Ventures, and Partnerships Share (by Company), January 2015-February 2019
  • Figure 5.5: Mergers and Acquisitions Share (by Company), January 2015- February 2019
  • Figure 5.6: Awards and Recognition (by Company), January 2015-February 2019
  • Figure 5.7: Business Expansion and Others Share (by Company), January 2015- February 2019
  • Figure 5.8: Market Share Analysis (by Company), for Global Interventional Oncology Devices Market, 2018
  • Figure 6.1: Market Dynamics
  • Figure 6.2: Trend of Robotic Surgery, Laparoscopic Surgery and Open Surgery, as a % of Select Surgeries, 2006 to 2015, U.K.
  • Figure 6.3: Household Disposable Income, US$/Capita
  • Figure 7.1: Segmentation of Interventional Oncology Devices Market (by Cancer Type)
  • Figure 7.2: Global Interventional Oncology Devices Market (by Cancer type), 2018 and 2025
  • Figure 7.3: Global Interventional Oncology Devices Market (Liver Cancer), 2018-2025
  • Figure 7.4: Global Interventional Oncology Devices Market (Lung Cancer), 2018-2025
  • Figure 7.5: Global Interventional Oncology Devices Market (Kidney Cancer), 2018-2025
  • Figure 7.6: Global Interventional Oncology Devices Market (Prostate Cancer), 2018-2025
  • Figure 7.7: Global Interventional Oncology Devices Market (by Other Cancers), 2018-2025
  • Figure 8.1: Segmentation of Interventional Oncology Devices Market (by Product type)
  • Figure 8.2: Global Interventional Oncology Devices Market (by Product type), 2018 and 2025
  • Figure 8.3: Global Interventional Oncology Devices Market (Ablation Devices), 2018-2025
  • Figure 8.4: Ablation is mainly divided into 3 types:
  • Figure 8.5. : Global Interventional Oncology Devices Market (Radiofrequency ablation devices), 2018-2025
  • Figure 8.6: Global Interventional Oncology Devices Market (Microwave Ablation Devices), 2018-2025
  • Figure 8.7: Global Interventional Oncology Devices Market (by Cryoablation Ablation Devices), 2018-2025
  • Figure 8.8: Global Interventional Oncology Devices Market (Embolization Devices), 2018-2025
  • Figure 8.9: Embolization is mainly divided into three types:
  • Figure 8.10: Global Interventional Oncology Devices Market (Transcatheter Arterial Radioembolization Devices), 2018-2025
  • Figure 8.11: Global Interventional Oncology Devices Market (Transcatheter arterial chemoembolization Devices), 2018-2025
  • Figure 8.12: Global Interventional Oncology Devices Market (Transcatheter arterial embolization devices), 2018-2025
  • Figure 8.13: Global Interventional Oncology Devices Market (Supporting Devices), 2018-2025
  • Figure 8.14: Global Interventional Oncology Devices Market (Next Generation Devices), 2018-2025
  • Figure 9.1: Global Interventional Oncology Devices Market (by Region), 2018 and 2025
  • Figure 9.2: North America: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.3: North America: Market Dynamics
  • Figure 9.4: North America: Interventional Oncology Devices Market (by Country), 2018 and 2025
  • Figure 9.5: U.S.: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.6: Canada: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.7: Europe: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.8: Europe: Market Dynamics
  • Figure 9.9: Europe: Interventional Oncology Devices Market (by Country), 2018 and 2024
  • Figure 9.10: Germany: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.11: France: Interventional oncology Devices Market, 2018-2025
  • Figure 9.12: U.K.: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.13: Italy: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.14: Rest-of-Europe: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.15: Asia-Pacific: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.16: Asia-Pacific: Market Dynamics
  • Figure 9.17: Asia-Pacific: Interventional Oncology Devices Market (by Country), 2018 and 2024
  • Figure 9.18: China: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.19: Japan: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.20: India: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.21: Australia: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.22: Rest-of-Asia-Pacific: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.23: Rest-of-the-World: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.24: Latin America: Interventional Oncology Devices Market, 2018-2025
  • Figure 9.25: Middle East and Africa: Interventional Oncology Devices Market, 2018-2025
  • Figure 10.1: Number of Companies Profiled: Global Interventional Oncology Devices Market, 2018
  • Figure 10.2: AngioDynamics, Inc.: Product Portfolio
  • Figure 10.3: AngioDynamics, Inc., Overall Financials, 2016-2018
  • Figure 10.4: AngioDynamics Inc., Total Sales Revenue (by Segment), 2016-2018
  • Figure 10.5: AngioDynamics, Inc. (by Region), 2016-2018
  • Figure 10.6: AngioDynamics Inc., R&D Expenditure, 2016-2018
  • Figure 10.7: AngioDynamics, Inc.: SWOT Analysis
  • Figure 10.8: BD: Product Portfolio
  • Figure 10.9: BD, Overall Financials, 2016-2018
  • Figure 10.10: BD, Total Sales Revenue (by Segment), 2016-2018
  • Figure 10.11: BD (by Region), 2016-2018
  • Figure 10.12: BD, Total Sales Revenue, 2016-2018
  • Figure 10.13: BD: SWOT Analysis
  • Figure 10.14: Boston Scientific Corporation: Product Portfolio
  • Figure 10.15: Boston Scientific Corporation, Overall Financials, 2016-2018
  • Figure 10.16: Boston Scientific Corporation, Total Sales Revenue (by Segment), 2016-2018
  • Figure 10.17: Boston Scientific Corporation (by Region), 2016-2018
  • Figure 10.18: Boston Scientific Corporation, R&D Expenditure, 2016-2018
  • Figure 10.19: Boston Scientific Corporation: SWOT Analysis
  • Figure 10.20: BTG Plc: Product Portfolio
  • Figure 10.21: BTG Plc, Overall Financials, 2016-2018
  • Figure 10.22: BTG Plc, Total Sales Revenue (by Segment), 2016-2018
  • Figure 10.23: BTG Plc (by Region), 2016-2018
  • Figure 10.24: BTG Plc, Total Sales Revenue, 2016-2018
  • Figure 10.25: BTG Plc: SWOT Analysis
  • Figure 10.26: Eckert & Ziegler BEBIG AG: Product Portfolio
  • Figure 10.27: Eckert & Ziegler BEBIG AG, Overall Financials, 2016-2018
  • Figure 10.28: Eckert & Ziegler BEBIG AG (by Region), 2016-2018
  • Figure 10.29: Eckert & Ziegler BEBIG AG Total Sales Revenue, 2016-2018
  • Figure 10.30: Eckert & Ziegler BEBIG AG: SWOT Analysis
  • Figure 10.31: HealthTronics, Inc.: Product Portfolio
  • Figure 10.32: HealthTronics, Inc.: SWOT Analysis
  • Figure 10.33: IceCure Medical: Product Portfolio
  • Figure 10.34: IceCure Medical: SWOT Analysis
  • Figure 10.35: Medtronic Plc: Product Portfolio
  • Figure 10.36: Medtronic PLC: Overall Financials, 2016-2018
  • Figure 10.37: Medtronic Plc, Total Sales Revenue (by Segment), 2016-2018
  • Figure 10.38: Medtronic Plc (by Region), 2016-2018
  • Figure 10.39: Medtronic PLC: R&D Expenditure
  • Figure 10.40: Medtronic PLC: SWOT Analysis
  • Figure 10.41: MedWaves, Inc.: Product Portfolio
  • Figure 10.42: MedWaves, Inc.: SWOT Analysis
  • Figure 10.43: Merit Medical Systems, Inc.: Product Portfolio
  • Figure 10.44: Merit Medical Systems, Inc., Overall Financials, 2016-2018
  • Figure 10.45: Merit Medical Systems, Inc., Total Sales Revenue (by Segment), 2016-2018
  • Figure 10.46: Merit Medical Systems, Inc. (by Region), 2016-2018
  • Figure 10.47: Merit Medical Systems, Inc., Total Sales Revenue, 2016-2018
  • Figure 10.48: Merit Medical Systems, Inc.: SWOT Analysis
  • Figure 10.49: Sanarus Technologies, Inc.: Product Portfolio
  • Figure 10.50: Sanarus Technologies, Inc.: SWOT Analysis
  • Figure 10.51: Sirtex Medical Ltd.: Product Portfolio
  • Figure 10.52: Sirtex Medical Ltd.: SWOT Analysis
  • Figure 10.53: Sonacare Medical: Product Portfolio
  • Figure 10.54: Sonacare Medical: SWOT Analysis
  • Figure 10.55: Terumo Corporation: Product Portfolio
  • Figure 10.56: Terumo Corporation, Overall Financials, 2015-2017
  • Figure 10.57: Terumo Corporation, Total Sales Revenue (by Segment), 2015-2017
  • Figure 10.58: Terumo Corporation, Total Sales Revenue (by Region), 2016-2018
  • Figure 10.59: Terumo Corporation, Total Sales Revenue, 2015-2017
  • Figure 10.60: Terumo Corporation: SWOT Analysis
  • Figure 10.61: Trod Medical: Product Portfolio
  • Figure 10.62: Trod Medical: SWOT Analysis
目次
Product Code: BH161A

"Global Interventional Oncology Devices Market to Reach $4.01 Billion by 2025, Reports BIS Research."

Key Questions Answered in this Report:

  • What are the key features of interventional oncology devices which makes them a better choice for the treatment of cancer?
  • What is the industry structure of the interventional oncology devices market?
  • How did the interventional oncology devices market evolve and what is its scope in the future?
  • What are the key development strategies which are implemented by the key players to maintain and capture market share?
  • What are the major market drivers, challenges, and opportunities in the global interventional oncology devices market?
  • What are the current leading companies dominating the global interventional oncology devices market?
  • What are the regulations pertaining to the global interventional oncology devices market? What are the initiatives implemented by different government bodies to reduce the incidence of cancer?
  • What was the market value of the leading segments and sub-segments of the global interventional oncology devices market?
  • How is each segment of the global interventional oncology devices market expected to grow during the forecast period and what is the revenue expected to be generated by each of the segments by the end of 2025?
  • Which region carries the potential for the significant expansion of key companies for interventional oncology devices market?

Global Interventional Oncology Devices Market Forecast, 2019-2025

Interventional Oncology Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 9.0% during the forecast period 2019-2025. The interventional oncology devices market generated $2.20 billion revenue in 2018, in terms of value.

The interventional oncology devices growth has been primarily attributed to the major drivers in this market such as increasing prevalence and growing incidence of cancer, favourable reimbursement scenario for interventional oncology treatment in developed countries, high preference for minimally invasive surgical procedures, availability of private and government funding, and others. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product launches, and increasing merger and acquisitions among the industry players. However, there are significant challenges which are restraining the market growth. These challenges include increasing financial burden on industry players with high number of product recalls and lack of clinical evidences for localized region treatment.

Expert Quote

"The addition of the BTG Interventional Medicine portfolio reinforces our category leadership strategy and enables us to offer best-in-class technologies, unparalleled clinical evidence and a strengthened commercial infrastructure to support physicians treating some of the most challenging diseases impacting patient health around the world."

Scope of the Market Intelligence on Interventional Oncology Devices Market

The interventional oncology devices market research provides a holistic view of global market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products used in interventional oncology procedures. In addition, the study also includes exhaustive information on impact of interventional oncology devices on various cancer types, perception on the new product launches, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segments, and company, as well as other vital information with respect to global interventional oncology devices market.

Market Segmentation

The interventional oncology devices market segmentation (based on product) is further segmented into embolization devices (transcatheter arterial radioembolization, transcatheter arterial chemoembolization, transcatheter arterial embolization), ablation devices (radiofrequency ablation, microwave ablation, and cryoablation), supporting devices, and next-gen devices.

The interventional oncology devices market segmentation (based on cancer type) is further segmented into liver, lung, kidney, prostate, and other cancer types.

Key Companies in the Global Interventional Oncology Devices Market

The key manufacturers who have been contributing significantly to the interventional oncology devices market include: AngioDynamics Inc., BD, BTG PLC, Boston Scientific Corporation, HealthTronics Inc., Medtronic PLC, Merit Medical Systems Inc., Sirtex Medical Ltd., and Terumo Corporation, among others.

Table of Contents

Executive Summary

1. Product Definition

  • 1.1. Embolization devices
  • 1.2. Ablation devices
  • 1.3. Supporting devices
  • 1.4. Next Gen devices

2. Scope of the Report

3. Research Methodology

  • 3.1. Research Methodology

4. Industry Analysis

  • 4.1. Regulatory Framework
  • 4.2. Patent Analysis

5. Competitive Landscape

  • 5.1. Key Strategies and Developments
    • 5.1.1. Product Launches
    • 5.1.2. Collaborations, Joint Ventures, and Partnerships
    • 5.1.3. Mergers and Acquisitions
    • 5.1.4. Awards, Recognitions, and Funding
    • 5.1.5. Business Expansion
  • 5.2. Vendor Market Share Analysis (2018)

6. Market Dynamics

  • 6.1. Overview
  • 6.2. Impact Analysis
  • 6.3. Market Drivers
    • 6.3.1 High Prevalence and Growing Incidences of Cancer
    • 6.3.2 Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Countries
    • 6.3.3 High preference for Minimally Invasive Surgical Procedures
    • 6.3.4 Expanding Role of Interventional Oncology in the Treatment of Cancer
    • 6.3.5. Availability of Private and Government Funding and Grants for Research in the Field of Interventional Oncology
    • 6.3.6. Rising Awareness among People for the Treatment of Cancer
    • 6.3.7. Increase in Disposable Income
  • 6.4. Market Challenges
    • 6.4.1. Financial Burden of Product Recalls
    • 6.4.2. Lack of Clinical Evidences for Locoregional Treatments
  • 6.5. Market Opportunities
    • 6.5.1. High Growth Opportunity in the Emerging Economies
  • 6.6. Market Restraints
    • 6.6.1. Dearth of Trained Interventional Oncologists

7. Global Interventional Oncology Devices Market (by Cancer Type)

  • 7.1. Overview
  • 7.2. Liver Cancer
  • 7.3. Lung Cancer
  • 7.4. Kidney Cancer
  • 7.5. Prostate Cancer
  • 7.6. Other Cancers

8. Global Interventional Oncology Devices Market (by Product type)

  • 8.1. Overview
  • 8.2. Ablation Devices
    • 8.2.1. Radiofrequency Ablation (RFA)
    • 8.2.2. Microwave Ablation
    • 8.2.3. Cryoablation
  • 8.3. Embolization Devices
    • 8.3.1. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
    • 8.3.2. Transcatheter Arterial Chemoembolization
    • 8.3.3. Transcatheter Arterial Embolization/Bland Embolization
  • 8.4. Supporting Devices
    • 8.4.1. Catheters
    • 8.4.2. Guidewires
  • 8.5. Next Generation Devices
    • 8.5.1. Irreversible Electroporation Ablation
    • 8.5.2. Percutaneous Ethanol Ablation
    • 8.5.3. High Intensity Focused Ultrasound
    • 8.5.4. Laser Ablation
    • 8.5.5. Photothermal Ablation
    • 8.5.6. Theranostics

9. Global Interventional Oncology Devices Market (by Region)

  • 9.1. Global Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Rest-of-Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. Rest-of-Asia-Pacific
  • 9.5. Rest-of-the-World
    • 9.5.1. Latin America
    • 9.5.2. Middle East and Africa

10. Company Profiles

  • 10.1. Overview
  • 10.2. AngioDynamics, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Role of AngioDynamics, Inc. in the Global Interventional Oncology Devices Market
    • 10.2.3. Key Developments
    • 10.2.4. Financials
    • 10.2.5. SWOT Analysis
  • 10.3. BD
    • 10.3.1. Company Overview
    • 10.3.2. Role of BD in the Global Advanced Interventional Oncology Devices Market
    • 10.3.3. Financials
    • 10.3.4. SWOT Analysis
  • 10.4. Boston Scientific Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Role of Boston Scientific Corporation in the Global Interventional Oncology Devices Market
    • 10.4.3. Key Development
    • 10.4.4. Financials
    • 10.4.5. SWOT Analysis
  • 10.5. BTG Plc
    • 10.5.1. Company Overview
    • 10.5.2. Role of BTG Plc in the Global Interventional Oncology Devices Market
    • 10.5.3. Key Development
    • 10.5.4. Financials
    • 10.5.5. SWOT Analysis
  • 10.6. Eckert & Ziegler BEBIG
    • 10.6.1. Company Overview
    • 10.6.2. Role of Eckert & Ziegler BEBIG AG in the Global Advanced Interventional Oncology Devices Market
    • 10.6.3. Financials
    • 10.6.4. SWOT Analysis
  • 10.7. HealthTronics, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Role of HealthTronics, Inc. in the Global Interventional Oncology Devices Market
    • 10.7.3. SWOT Analysis
  • 10.8. IceCure Medical
    • 10.8.1. Company Overview
    • 10.8.2. Role of IceCure Medical in the Global Interventional Oncology Devices Market
    • 10.8.3. Key Development
    • 10.8.4. SWOT Analysis
  • 10.9. Medtronic PLC
    • 10.9.1. Overview
    • 10.9.2. Role of Medtronic PLC in the Global Interventional Oncology Devices Market
    • 10.9.3. Key Development
    • 10.9.4. Financials
    • 10.9.5. SWOT Analysis
  • 10.10 Medwaves, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Role of MedWaves, Inc. in the Global Interventional Oncology Devices Market
    • 10.10.3. SWOT Analysis
  • 10.11 Merit Medical Systems, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Role of Merit Medical Systems, Inc. in the Global Interventional Oncology Devices Market
    • 10.11.3. Financials
    • 10.11.4. SWOT Analysis
  • 10.12 Sanarus Technologies, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Role of Sanarus Technologies, Inc. in the Global Interventional Oncology Devices Market
    • 10.12.3. Key Development
    • 10.12.4. SWOT Analysis
  • 10.13 Sirtex Medical Ltd. (China Grand Pharmaceutical and Healthcare Holdings Limited; CDH Genetech, Ltd.)
    • 10.13.1. Company Overview
    • 10.13.2. Role of Sirtex Medical Ltd. In the Global Advanced Interventional Oncology Devices Market
    • 10.13.3. Financials
    • 10.13.4. SWOT Analysis
  • 10.14 Sonacare Medical
    • 10.14.1. Company Overview
    • 10.14.2. Role of Sonacare Medical in the Global Interventional Oncology Devices Market
    • 10.14.3. Key Development
    • 10.14.4. SWOT Analysis
  • 10.15 Terumo Corporation
    • 10.15.1. Company Overview
    • 10.15.2. Role of Terumo Corporation in the Global Interventional Oncology Devices Market
    • 10.15.3. Financials
    • 10.15.4. SWOT Analysis
  • 10.16 Trod Medical
    • 10.16.1. Company Overview
    • 10.16.2. Role of Trod Medical in the Global Interventional Oncology Devices Market
    • 10.16.3. SWOT Analysis
Back to Top